The Australian Rheumatology Association (ARA) and Arthritis Australia are pleased to provide the following patient information, for your easy access and downloading.

The development of the Medicine Information Sheets has been a collaborative effort between many members of the ARA in consultation with Arthritis Australia and Communicating for Health, Victoria.  Major credits must go to the past and present members of the ARA Therapeutics Committee for their efforts in delivering these most useful sheets to us.  They have recently been extensively revised using feedback from patients focus groups and new information. We would welcome any feedback on the sheets and where they could be improved for future updates.  Comments can be forwarded to the ARA Secretariat: admin@rheumatology.org.au

  • Abatacept (Brand name: Orencia) updated February 2016
  • Adalimumab (Brand name: Humira) updated February 2016
  • Allopurinol (Brand names: Allohexal, Allosig, Progout, Zyloprim) updated February 2016
  • Ambrisentan (Brand name: Volibris) updated February 2016
  • Anakinra (Brand name: Kineret) updated February 2016
  • Apremilast (Brand name: Otezla®) updated October 2015
  • Azathioprine (Brand names: Azamun, Azapin, Imuran, Thioprine) updated November 2016
  • Bisphosphonates (Intravenous/IV) (Brand names: Aclasta, Aredia) updated July 2017
  • Bisphosphonates (oral) (Brand names: Adronat, Alendrobell, Alendro, Fosamax, Ossmax, Acris, Actonel, Actonel Combi, Actonel, Risedro) updated August 2012
  • Bosentan (Brand name: Tracleer®) updated November 2016
  • Certolizumab (Brand name: Cimzia) updated March 2014
  • Colchicine (Brand names: Colgout, Lengout) updated October 2016
  • Cyclophosphamide (Brand names: Cyclonex® Endoxan®) updated November 2016
  • Cyclosporin (Brand names: Cicloral, Neoral, Sandimmun) updated July 2017
  • Denosumab (Brand name: Prolia) updated July 2017
  • D-Penicillamine (Brand name: D-Penamine) updated February 2017
  • Febuxostat (Brand name: Adenuric) updated September 2015
  • Etanercept (Brand name: Enbrel) updated July 2017
  • Gold (Brand names: Myocrisin, Ridaura) updated July 2017
  • Golimumab (Brand name: Simponi) updated February 2016
  • Hyaluronic Acid (Brand names: Synvisc, Orthoartz) updated May 2016
  • Hydroxychloroquine (Brand name: Plaquenil) updated April 2016
  • Infliximab (Brand name: Remicade) updated July 2017
  • IV Immunuglobulin (Brand names: Intragam P®, Flebogamma®, Privigen®, Intratect®, Octagam®, Kiovig®, Gamunex®) updated July 2016
  • Leflunomide (Brand names: Arabloc, Arava, Lunava) updated October 2016
  • Methotrexate (Brand name: Methoblastin) updated April 2017
  • Self-injecting Methotrexate for the treatment of arthritis (Brand names: Hospira, Methacord, Methotrexate Accord) updated October 2017
  • Mycophenolate (Brand names: CellCept, Imulate, Ceptolate, Myfortic) updated February 2016
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (Brand names: Nurofen, Brufen, Mobic, Celebrex, Naprosyn, Orudis, Arcoxia, Voltaren) updated February 2017
  • Paracetamol (Brand names: Dymadon, Febridol, Panadol, Panamax, Paralgin, Panadol Osteo) updated February 2016
  • Prednisolone and Prednisone (Brand names: Panafcort, Panafcortelone, Predsone, Predsolone, Solone, Sone) updated February 2016
  • Probenecid (Brand name: Pro-Cid) updated February 2016
  • Raloxifene (Brand name: Evista) updated April 2020
  • Rituximab (Brand name: Mabthera) updated April 2016
  • Secukinumab (Brand name: Cosentyx®) updated November 2016
  • Strontium (Brand name: Protos®) updated February 2016
  • Sulfasalazine (Brand names: Pyralin EN, Salazopyrin, Salazopyrin EN) updated April 2016
  • Teriparatide (Brand name: Forteo®) updated February 2016
  • Tocilizumab (Brand name: Actemra) updated February 2017
  • Tofacitinib (Brand name: Xeljanz®) updated May 2016
  • Ustekinumab (Brand name: Stelara) updated October 2015